Press Releases

One2Treat, the leading company incorporating the patient voice into clinical development, launches One2Treat Voice app

One2Treat SA, a fast-growing tech company incorporating the patient voice in all strategic decisions about treatment assessments in Pharma R&D, today announced the launch of the One2Treat Voice app, a new module of their software platform.

Astoriom Appoints Brittany Jackson as CFO

Key appointment to lead the company’s financial strategy and support continued global growth in sample stability and biorepository storage solutions

ClearNote Health Avantect® Pancreatic Cancer Test Enters Patient Enrollment Phase of Groundbreaking UK Study Targeting High-Risk Patients

ClearNote Health announced initiation of patient enrollment for a new study that aims to advance early detection of pancreatic cancer in individuals newly diagnosed with type 2 diabetes.

Majority of Diagnostic Laboratory Leaders Bet Big on Digital Pathology and AI

Survey of 360 senior professionals finds modernization is key to overcoming longstanding industry challenges.

Echosens and Boehringer Ingelheim Expand Long-Standing Collaboration to Accelerate Progress in MASH Diagnosis and Care

Echosens and Boehringer Ingelheim have expanded their long-standing partnership to accelerate progress in MASH diagnosis and care.

TeleTracking and Palantir Partner to Transform Healthcare Operations with AI-Powered Insights

Industry Leading RBQM Event Returns for 2025

CluePoints, the premier sponsor of RBQMLive and provider of leading statistical and AI-driven software solutions, has announced the full agenda and expert speaker line up for the 4th annual, award-winning event, RBQMLive.

4D Path Presents Breakthrough Research Demonstrating That Its Unique Digital Predictive Biomarker Identifies Treatment Responders in a Difficult-To-Treat Breast Cancer Patient Population

4D Path, a company dedicated to personalizing cancer care through its unprecedented approach to predicting tumor response, unveiled groundbreaking findings at the American Society of Clinical Oncology (ASCO) 2025 Annual Meeting, revealing the first predictive biomarker of its kind for breast cancer patients traditionally considered unlikely to respond to treatment.

Thermo Fisher Scientific Launches New Spectral Flow Cytometer Offering Increased Speed, Versatility and Reliability to Labs

4D Path to Present New Data Demonstrating Enhanced Prediction of Chemotherapy Response in BRCA-Mutated and HER2-Negative Breast Cancer at ASCO 2025

4D Path, a company dedicated to personalizing cancer care through its unprecedented approach to predicting tumor response, today announced that the company will present new clinical data at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting from May 30–June 3 in Chicago, IL.

Ambience Healthcare's AI Platform Surpasses Clinician Performance by 27% in Medical Coding, Powered by New OpenAI Breakthrough

Association for Molecular Pathology Releases Series of Reports Defining Core Bioinformatics Competencies for Clinical Diagnostic Laboratories

AMP announced the release of a three-part series of papers on core bioinformatics capabilities for professionals in clinical molecular diagnostic labs.

Astoriom Expands Global Footprint for Sample Stability Storage Services

Growth in dedicated sample stability facilities at Tramore (Ireland) site to meet demand for flexible, regulatory-compliant storage solutions

4D Path Expands Scientific Advisory Board with Global Leaders in Oncology and Pathology

4D Path, a company dedicated to personalizing cancer care through its unprecedented approach to predicting tumor response, recently convened its Scientific Advisory Board (SAB), bringing together an exceptional group of oncology, pathology, and translational research leaders, each deeply committed to advancing precision oncology and translating innovation into patient impact.

Onvida Health and Ambience Healthcare Partner to Enhance Patient Care and Revolutionize Clinical Workflows with AI Technology

eClinical Solutions Welcomes Sean Lannan as Chief Financial Officer

Lannan and new Board of Directors member Jason Blessing will help propel the company’s next phase of growth

ELRIG Announces Keynote Speakers for Drug Discovery 2025

• Prof Heather Pinkett and Dr Dafydd Owen to lead ELRIG’s flagship event • Drug Discovery returns to Liverpool, 21–22 October 2025 to celebrate “A Festival of Life Science” • Event supported by VisitBritain showcases UK life science sector and extends international reach

Longhorn Vaccines and Diagnostics Validates Efficacy of PrimeStore® Molecular Transport Medium (MTM) to Inactivate Deadly Pathogens

Longhorn Vaccines and Diagnostics Validates Efficacy of PrimeStore® Molecular Transport Medium (MTM) to Inactivate Deadly Pathogens in NIH Study

Sunnen Products Company Highlights the PGE-6000 Gage with Advanced Precision for Medical Applications

Sunnen's cutting-edge bore gaging system offers unmatched precision, versatility, and efficiency for high-precision measurement needs in medical device manufacturing.

Proscia Wins 2025 MedTech Breakthrough Award

Proscia's Concentriq AP-Dx*software platform was recognized for innovation, performance, value, and impact as digital pathology increasingly enters the mainstream.